Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa

作者: Qing-Zhu Yang , Che Wang , Lei Lang , Yang Zhou , He Wang

DOI: 10.1007/S12272-013-0112-8

关键词: Rational designPeptideTemporinChemistryHemolysisCytotoxicityStructure–activity relationshipPharmacologyAntimicrobialAntimicrobial peptidesOrganic chemistryMolecular medicineDrug discovery

摘要: Recent advances in the search for novel anticancer agents have indicated that positively charged antimicrobial peptides emerged as promising offering several advantages over conventional drugs. As a naturally occurring, cationic, α-helical peptide, temproin-1CEa has been proved to exhibit potent effect and moderate hemolytic activity. In order reduce activity of temporin-1CEa improve its potency towards range human breast cancer cells, present study, six analogs were rationally designed synthesized. The amphipathicity levels structural patterns reserved, while their cationic property hydrophobicity changed. results MTT hemolysis assay analog displayed an improved showed overall optimized therapeutic index. was correlated with antitumor activities. Moreover, data suggest strategy increasing cationicity maintaining occurring amphipathic generate cytotoxicity against tumor cells but decreased non-neoplastic such erythrocytes. This work highlights potential rational design synthesis capability be used therapeutically treatment cancers.

参考文章(29)
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, C. Smigal, M. J. Thun, Cancer statistics, 2006. CA: A Cancer Journal for Clinicians. ,vol. 56, pp. 106- 130 ,(2006) , 10.3322/CANJCLIN.56.2.106
David Eisenberg, Robert M. Weiss, Thomas C. Terwilliger, The helical hydrophobic moment: a measure of the amphiphilicity of a helix Nature. ,vol. 299, pp. 371- 374 ,(1982) , 10.1038/299371A0
Torsten Wieprecht, Margitta Dathe, Michael Beyermann, Eberhard Krause, W. Lee Maloy, Dorothy L. MacDonald, Michael Bienert, Peptide hydrophobicity controls the activity and selectivity of magainin-2 amide in interaction with membranes Biochemistry. ,vol. 36, pp. 6124- 6132 ,(1997) , 10.1021/BI9619987
Dominik Ausbacher, Gunbjørg Svineng, Terkel Hansen, Morten B. Strøm, Anticancer mechanisms of action of two small amphipathic β(2,2)-amino acid derivatives derived from antimicrobial peptides. Biochimica et Biophysica Acta. ,vol. 1818, pp. 2917- 2925 ,(2012) , 10.1016/J.BBAMEM.2012.07.005
Robert E W Hancock, Hans-Georg Sahl, Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nature Biotechnology. ,vol. 24, pp. 1551- 1557 ,(2006) , 10.1038/NBT1267
Lewis L. Smith, Karen Brown, Philip Carthew, Chang-Kee Lim, Elizabeth A. Martin, Jerry Styles, Ian N. H. White, Chemoprevention of breast cancer by tamoxifen: risks and opportunities. Critical Reviews in Toxicology. ,vol. 30, pp. 571- 594 ,(2000) , 10.1080/10408440008951120
Mohsen Shadidi, Mouldy Sioud, Selective targeting of cancer cells using synthetic peptides. Drug Resistance Updates. ,vol. 6, pp. 363- 371 ,(2003) , 10.1016/J.DRUP.2003.11.002
Edgar J. Paredes-Gamero, Marta N.C. Martins, Fábio A.M. Cappabianco, Jaime S. Ide, Antonio Miranda, Characterization of dual effects induced by antimicrobial peptides: regulated cell death or membrane disruption. Biochimica et Biophysica Acta. ,vol. 1820, pp. 1062- 1072 ,(2012) , 10.1016/J.BBAGEN.2012.02.015
Carola Leuschner, William Hansel, Membrane disrupting lytic peptides for cancer treatments. Current Pharmaceutical Design. ,vol. 10, pp. 2299- 2310 ,(2004) , 10.2174/1381612043383971